基本信息
浏览量:88
职业迁徙
个人简介
Prof Hogg has made novel, small-molecule inhibitors of mitochondrial adenine nucleotide translocase (ANT), GSAO and PENAO, that are currently being trialled in patients with solid tumours. Cystemix Pty Ltd was formed to manage the commercial development of this suite of drugs. Prof Hogg has invented an effective small molecule non-invasive imaging agent for dying and dead cells. This technology will have many applications both in the research arena and in clinical practice. Its most obvious clinical utility is for monitoring cancer therapy.
研究兴趣
论文共 289 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of thrombosis and haemostasis : JTHno. 8 (2023): 2089-2100
Venessa Chin, Himanshi Arora,Jose Alquicira-Hernandez, Anne Sennabouth,Rachael McCloy,John Simes,Michael Boyer,Philip Hogg,Jane Young,Anthony Joshua,Bea Brown,Joseph Powell
引用0浏览0引用
0
0
NUCLEAR MEDICINE AND BIOLOGY (2023): 108380-108380
Alexander Dupuy, Camilo Aponte Santamaría,Adva Yeheskel,Elinor Hortle,Stefan H Oehlers,Frauke Gräter,Philip J Hogg,Freda H Passam,Joyce Chiu
Circulation research (2023)
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn